Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Johnson & Johnson Upgraded On Synthes Approval
Motley Fool
Saturday, June 23, 2012 - 12:06pm
tags:
JNJ, Synthes
NVO Candidate to Step into Phase III
Yahoo/Zacks
Saturday, June 23, 2012 - 12:05pm
tags:
Novo Nordisk, semaglutide, diabetes, type 2 diabetes
Healthcare Biz Recap: J&J Blocked, Repligen Craters, Arena AXED
Wall Street Cheat Street
Saturday, June 23, 2012 - 12:03pm
tags:
JNJ, Repligen, Arena Pharmaceuticals
These Stocks Avoided the Market's Squeeze
Motley Fool
Saturday, June 23, 2012 - 12:02pm
tags:
Celgene, Chelsea Therapeutics, ONYX Pharmaceuticals
Momenta Pharmaceuticals Announces Decision in Teva Patent Litigation
Yahoo/GlobeNewsWire
Saturday, June 23, 2012 - 12:01pm
tags:
Momenta, Teva Pharmaceuticals, Patent Infringement, lawsuits
Cramer: What Celgene’s Europe News Means
CNBC
Saturday, June 23, 2012 - 12:00pm
tags:
Celgene, Revlimid, ONYX Pharmaceuticals, kidney cancer, liver cancer
Osiris Keeps Neutral Recommendation
Yahoo/Zacks
Saturday, June 23, 2012 - 11:55am
tags:
Osiris Therapeutics
Arena Sold Out? (video)
CNBC
Saturday, June 23, 2012 - 11:53am
tags:
Arena Pharmaceuticals, lorcaserin, obesity, weight loss
Former Drug Developer Discovers Next-Generation Biotech Stocks
Motley Fool
Saturday, June 23, 2012 - 11:52am
tags:
Amarin, Ironwood Pharmaceuticals, Medivation
Arena Declines As Column Warns Of Crash After 10-Day Run
Bloomberg
Saturday, June 23, 2012 - 11:49am
tags:
Arena Pharmaceuticals, lorcaserin, obesity, weight loss
Intermune Concludes Sale of Actimmune
Yahoo/Zacks
Saturday, June 23, 2012 - 11:48am
tags:
InterMune, Actimmune
Will Patience Pay for Arena’s Biggest Fans Awaiting the Final Answer?
Wall Street Cheat Street
Saturday, June 23, 2012 - 11:43am
tags:
Arena, lorcaserin, obesity, weight loss
Coronado Biosciences prices offering of 5M shares
Yahoo/AP
Saturday, June 23, 2012 - 11:42am
tags:
Coronado Biosciences
3 Rallying Drug-Makers Being Snapped Up By Insiders
Seeking Alpha
Friday, June 22, 2012 - 4:01pm
tags:
Pacira, Pharmacyclics, Ardea Biosciences
Alexza rockets 30% on FDA update
Marketwatch
Friday, June 22, 2012 - 4:00pm
tags:
Alexza, FDA, bipolar disorder, Adasuve
Why are Obesity Stocks Suddenly So Hot?
Motley Fool
Friday, June 22, 2012 - 3:52pm
tags:
obesity, lorcaserin, Arena Pharmaceuticals, Vivus, Qnexa, Orexigen, Contrave
Coronado Biosciences prices offering of 5M shares, expects proceeds of about $23M
Yahoo/AP
Friday, June 22, 2012 - 3:51pm
tags:
Coronado Biosciences, stock offering
Arena shares slump 14 pct before diet drug ruling
Reuters
Friday, June 22, 2012 - 3:46pm
tags:
Arena Pharmaceuticals, lorcaserin, FDA, obesity
NVO Candidate to Step into Phase III
Yahoo/Zacks
Friday, June 22, 2012 - 3:30pm
tags:
Novo Nordisk, semaglutide, diabetes
Wisconsin Supreme Court upholds damages awarded in Medicaid drug lawsuit
Yahoo/AP
Friday, June 22, 2012 - 3:29pm
tags:
Wisconsin, Medicaid, lawsuits, Pharmacia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.